4-Aminopyridine is a promising treatment option for patients with gain-of-function
KCNA2
-encephalopathy
Science Translational Medicine | September 2, 2021 | Volume: 13 | Issue: 609 | Pages: No page available
10.1126/scitranslmed.aaz4957
| PMID 34516822
4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.